Results 61 to 70 of about 162,788 (297)

The evolution of moral progress and biomedical moral enhancement [PDF]

open access: yesBioethics, 2019
AbstractIn The Evolution of Moral Progress Allen Buchanan and Russell Powell advance an evolutionary explanation of moral progress by morality becoming more ‘inclusivist’. We are prepared to accept this explanation as far as it goes, but argue that it fails to explain how morality can become inclusivist in the fuller sense they intend. In fact, it even
Ingmar Persson, Julian Savulescu
openaire   +3 more sources

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

Inequality and Discrimination in Biomedical Enhancement

open access: yes, 2022
In this thesis I discuss how existing inequlity and discrimination has shaped the discourse on biomedical enhancement and how the bioenhancement project can potentially exasperate them.
M Dede (21853364)
core  

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov   +3 more
wiley   +1 more source

Biomedical Moral Enhancement for Human Space Missions

open access: yes, 2019
Biomedical moral enhancement is an idea which states that human moral intuitions and patterns may be artificially improved by biomedical means. The rationale which lies behind moral bioenhancement is rooted in the idea that humans – in a moral and ...
Szocik Konrad
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Sensitivity enhancement in swept-source optical coherence tomography by parametric balanced detector and amplifier

open access: yes, 2016
We report a sensitivity enhancement method in interference signal detection of swept-source optical coherence tomography with all-fiber parametric amplifier and balanced detector.
Jiqiang Kang   +14 more
core   +1 more source

Tensor Methods in Biomedical Image Analysis

open access: yesJournal of Medical Signals and Sensors
In the past decade, tensors have become increasingly attractive in different aspects of signal and image processing areas. The main reason is the inefficiency of matrices in representing and analyzing multimodal and multidimensional datasets.
Farnaz Sedighin
doaj   +1 more source

Privacy-enhancing ETL-processes for biomedical data

open access: yesInternational Journal of Medical Informatics, 2019
Modern data-driven approaches to medical research require patient-level information at comprehensive depth and breadth. To create the required big datasets, information from disparate sources can be integrated into clinical and translational warehouses. This is typically implemented with Extract, Transform, Load (ETL) processes, which access, harmonize
Fabian Prasser   +4 more
openaire   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy